Anchored in research undertaken at University of Georgia by that person who went on to found the firm - investigating muscle stem cell biology and muscle regeneration, HAWA Therapeutics, LLC is a startup based on the HIF2A skeletal muscle regeneration technology developed. The company has also tackled work establishing proof-of-principles for two medicinal formulations of HIF2A inhibitors.